Given that high Hem1 is associated with poor clinical outcome in CLL, it would be important to understand how high Hem1 expression moderates cancer progression at the cellular level, whether it be facilitation of invasion, increased adhesion of cancer cells into chemoprotective niches, and or adaptation to less hospitable environments (120). The gene discussed is NCKAP1L; the disease is B-cell chronic lymphocytic leukemia.